163 related articles for article (PubMed ID: 12915448)
1. The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain.
Ganesh S; Tsurutani N; Suzuki T; Ueda K; Agarwala KL; Osada H; Delgado-Escueta AV; Yamakawa K
Hum Mol Genet; 2003 Sep; 12(18):2359-68. PubMed ID: 12915448
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease.
Girard JM; Lê KH; Lederer F
Biochimie; 2006 Dec; 88(12):1961-71. PubMed ID: 17010495
[TBL] [Abstract][Full Text] [Related]
3. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes.
Ganesh S; Agarwala KL; Ueda K; Akagi T; Shoda K; Usui T; Hashikawa T; Osada H; Delgado-Escueta AV; Yamakawa K
Hum Mol Genet; 2000 Sep; 9(15):2251-61. PubMed ID: 11001928
[TBL] [Abstract][Full Text] [Related]
4. Regional and developmental expression of Epm2a gene and its evolutionary conservation.
Ganesh S; Agarwala KL; Amano K; Suzuki T; Delgado-Escueta AV; Yamakawa K
Biochem Biophys Res Commun; 2001 May; 283(5):1046-53. PubMed ID: 11355878
[TBL] [Abstract][Full Text] [Related]
5. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
[TBL] [Abstract][Full Text] [Related]
6. Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase.
Wang W; Roach PJ
Biochem Biophys Res Commun; 2004 Dec; 325(3):726-30. PubMed ID: 15541350
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions.
Gómez-Garre P; Sanz Y; Rodríguez De Córdoba SR; Serratosa JM
Eur J Hum Genet; 2000 Dec; 8(12):946-54. PubMed ID: 11175283
[TBL] [Abstract][Full Text] [Related]
8. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.
Ganesh S; Tsurutani N; Suzuki T; Hoshii Y; Ishihara T; Delgado-Escueta AV; Yamakawa K
Biochem Biophys Res Commun; 2004 Jan; 313(4):1101-9. PubMed ID: 14706656
[TBL] [Abstract][Full Text] [Related]
9. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
[TBL] [Abstract][Full Text] [Related]
10. [Molecular genetics of epilepsy].
Yamakawa K
Rinsho Shinkeigaku; 2004 Nov; 44(11):858-60. PubMed ID: 15651314
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product.
Ianzano L; Zhao XC; Minassian BA; Scherer SW
Genomics; 2003 Jun; 81(6):579-87. PubMed ID: 12782127
[TBL] [Abstract][Full Text] [Related]
12. Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.
Ganesh S; Shoda K; Amano K; Uchiyama A; Kumada S; Moriyama N; Hirose S; Yamakawa K
Mol Cell Probes; 2001 Oct; 15(5):281-9. PubMed ID: 11735300
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli expression, refolding and characterization of human laforin.
Castanheira P; Moreira S; Gama M; Faro C
Protein Expr Purif; 2010 Jun; 71(2):195-9. PubMed ID: 20152902
[TBL] [Abstract][Full Text] [Related]
14. A chloroplast-localized dual-specificity protein phosphatase in Arabidopsis contains a phylogenetically dispersed and ancient carbohydrate-binding domain, which binds the polysaccharide starch.
Kerk D; Conley TR; Rodriguez FA; Tran HT; Nimick M; Muench DG; Moorhead GB
Plant J; 2006 May; 46(3):400-13. PubMed ID: 16623901
[TBL] [Abstract][Full Text] [Related]
15. Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.
Srikumar PS; Rohini K
Appl Biochem Biotechnol; 2013 Oct; 171(4):874-82. PubMed ID: 23904258
[TBL] [Abstract][Full Text] [Related]
16. A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen.
Wang J; Stuckey JA; Wishart MJ; Dixon JE
J Biol Chem; 2002 Jan; 277(4):2377-80. PubMed ID: 11739371
[TBL] [Abstract][Full Text] [Related]
17. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy.
Minassian BA; Ianzano L; Meloche M; Andermann E; Rouleau GA; Delgado-Escueta AV; Scherer SW
Neurology; 2000 Aug; 55(3):341-6. PubMed ID: 10932264
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A.
Ganesh S; Amano K; Delgado-Escueta AV; Yamakawa K
Biochem Biophys Res Commun; 1999 Apr; 257(1):24-8. PubMed ID: 10092504
[TBL] [Abstract][Full Text] [Related]
19. Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
Wang W; Parker GE; Skurat AV; Raben N; DePaoli-Roach AA; Roach PJ
Biochem Biophys Res Commun; 2006 Nov; 350(3):588-92. PubMed ID: 17022935
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
